Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension
- PMID: 18071071
- DOI: 10.1161/CIRCULATIONAHA.107.728550
Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension
Abstract
Background: Excessive diastolic left ventricular stiffness is an important contributor to heart failure in patients with diabetes mellitus. Diabetes is presumed to increase stiffness through myocardial deposition of collagen and advanced glycation end products (AGEs). Cardiomyocyte resting tension also elevates stiffness, especially in heart failure with normal left ventricular ejection fraction (LVEF). The contribution to diastolic stiffness of fibrosis, AGEs, and cardiomyocyte resting tension was assessed in diabetic heart failure patients with normal or reduced LVEF.
Methods and results: Left ventricular endomyocardial biopsy samples were procured in 28 patients with normal LVEF and 36 patients with reduced LVEF, all without coronary artery disease. Sixteen patients with normal LVEF and 10 with reduced LVEF had diabetes mellitus. Biopsy samples were used for quantification of collagen and AGEs and for isolation of cardiomyocytes to measure resting tension. Diabetic heart failure patients had higher diastolic left ventricular stiffness irrespective of LVEF. Diabetes mellitus increased the myocardial collagen volume fraction only in patients with reduced LVEF (from 14.6+/-1.0% to 22.4+/-2.2%, P<0.001) and increased cardiomyocyte resting tension only in patients with normal LVEF (from 5.1+/-0.7 to 8.5+/-0.9 kN/m2, P=0.006). Diabetes increased myocardial AGE deposition in patients with reduced LVEF (from 8.8+/-2.5 to 24.1+/-3.8 score/mm2; P=0.005) and less so in patients with normal LVEF (from 8.2+/-2.5 to 15.7+/-2.7 score/mm2, P=NS).
Conclusions: Mechanisms responsible for the increased diastolic stiffness of the diabetic heart differ in heart failure with reduced and normal LVEF: Fibrosis and AGEs are more important when LVEF is reduced, whereas cardiomyocyte resting tension is more important when LVEF is normal.
Comment in
-
Letter by Connelly et al regarding article, "Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension".Circulation. 2008 Jun 10;117(23):e483; author reply e484. doi: 10.1161/CIRCULATIONAHA.108.769513. Circulation. 2008. PMID: 18541748 No abstract available.
Similar articles
-
Cardiomyocyte stiffness in diastolic heart failure.Circulation. 2005 Feb 15;111(6):774-81. doi: 10.1161/01.CIR.0000155257.33485.6D. Epub 2005 Feb 7. Circulation. 2005. PMID: 15699264
-
Myocardial structure and function differ in systolic and diastolic heart failure.Circulation. 2006 Apr 25;113(16):1966-73. doi: 10.1161/CIRCULATIONAHA.105.587519. Epub 2006 Apr 17. Circulation. 2006. PMID: 16618817
-
Letter by Connelly et al regarding article, "Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension".Circulation. 2008 Jun 10;117(23):e483; author reply e484. doi: 10.1161/CIRCULATIONAHA.108.769513. Circulation. 2008. PMID: 18541748 No abstract available.
-
Heart failure in elderly patients.Exp Gerontol. 2006 May;41(5):549-51. doi: 10.1016/j.exger.2006.03.002. Epub 2006 Apr 18. Exp Gerontol. 2006. PMID: 16621389 Review.
-
Role of exercise and metabolism in heart failure with normal ejection fraction.Prog Cardiovasc Dis. 2007 Jan-Feb;49(4):263-74. doi: 10.1016/j.pcad.2006.08.006. Prog Cardiovasc Dis. 2007. PMID: 17185114 Review.
Cited by
-
Mechanistic validation of the 2016 American Society of Echocardiography/European Association of Cardiovascular Imaging Guidelines for the assessment of diastolic dysfunction in heart failure with reduced ejection fraction.Cardiovasc Ultrasound. 2020 Oct 16;18(1):42. doi: 10.1186/s12947-020-00224-z. Cardiovasc Ultrasound. 2020. PMID: 33066772 Free PMC article.
-
HbA1c and FIB-4 as serologic markers for the risk of progression of stage A heart failure.Glob Cardiol Sci Pract. 2021 Dec 31;2021(4):e202125. doi: 10.21542/gcsp.2021.25. eCollection 2021 Dec 31. Glob Cardiol Sci Pract. 2021. PMID: 36185157 Free PMC article.
-
Advanced glycation end product cross-link breaker attenuates diabetes-induced cardiac dysfunction by improving sarcoplasmic reticulum calcium handling.Front Physiol. 2012 Jul 19;3:292. doi: 10.3389/fphys.2012.00292. eCollection 2012. Front Physiol. 2012. PMID: 22934044 Free PMC article.
-
Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction.J Cardiovasc Transl Res. 2013 Aug;6(4):501-15. doi: 10.1007/s12265-013-9472-1. Epub 2013 May 29. J Cardiovasc Transl Res. 2013. PMID: 23716130 Review.
-
MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin.Cardiovasc Diabetol. 2018 Sep 4;17(1):123. doi: 10.1186/s12933-018-0767-z. Cardiovasc Diabetol. 2018. PMID: 30180843 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous